Found: 77
Select item for more details and to access through your institution.
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00670-2
- By:
- Publication type:
- Article
Low-risk DCIS. What is it? Observe or excise?
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 1, p. 21, doi. 10.1007/s00428-021-03173-8
- By:
- Publication type:
- Article
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The influence of field strength and different clinical breast MRI protocols on the outcome of texture analysis using foam phantoms.
- Published in:
- Medical Physics, 2011, v. 38, n. 9, p. 5058, doi. 10.1118/1.3622605
- By:
- Publication type:
- Article
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mortality Associated with the Treatment of Gallstone Disease: A 10-Year Contemporary National Experience.
- Published in:
- World Journal of Surgery, 2011, v. 35, n. 3, p. 643, doi. 10.1007/s00268-010-0908-3
- By:
- Publication type:
- Article
Delay from Symptom Onset Increases the Conversion Rate in Laparoscopic Cholecystectomy for Acute Cholecystitis.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 3, p. 457, doi. 10.1007/s10549-023-06929-9
- By:
- Publication type:
- Article
The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 1, p. 221, doi. 10.1007/s10549-019-05377-8
- By:
- Publication type:
- Article
TP53 drives invasion through expression of its Δ133p53β variant.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.14734
- By:
- Publication type:
- Article
Beyond the Margins-Economic Costs and Complications Associated With Repeated Breast-Conserving Surgeries.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231189422
- By:
- Publication type:
- Article
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 11, p. 3510, doi. 10.1245/s10434-019-07577-4
- By:
- Publication type:
- Article
Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
- Published in:
- Journal of Pathology, 2014, v. 233, n. 3, p. 238, doi. 10.1002/path.4356
- By:
- Publication type:
- Article
p53 transcriptional pathways in breast cancer: the good, the bad and the complex.
- Published in:
- Journal of Pathology, 2010, v. 220, n. 4, p. 401, doi. 10.1002/path.2674
- By:
- Publication type:
- Article
An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170.
- Published in:
- Journal of Pathology, 1998, v. 186, n. 3, p. 254, doi. 10.1002/(SICI)1096-9896(1998110)186:3<254::AID-PATH185>3.0.CO;2-U
- By:
- Publication type:
- Article
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127713
- By:
- Publication type:
- Article
A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2788-x
- By:
- Publication type:
- Article
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab066
- By:
- Publication type:
- Article
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00275-z
- By:
- Publication type:
- Article
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41523-020-00202-8
- By:
- Publication type:
- Article
Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 653, doi. 10.1111/bcp.13152
- By:
- Publication type:
- Article
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3275, doi. 10.3390/cancers15133275
- By:
- Publication type:
- Article
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1323, doi. 10.3390/cancers14051323
- By:
- Publication type:
- Article
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 390, doi. 10.3390/cancers10100390
- By:
- Publication type:
- Article
Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation.
- Published in:
- Oncogene, 1999, v. 18, n. 46, p. 6305, doi. 10.1038/sj.onc.1203085
- By:
- Publication type:
- Article
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 2, p. 1, doi. 10.1186/bcr3630
- By:
- Publication type:
- Article
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom.
- Published in:
- 2012
- By:
- Publication type:
- journal article
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2811
- By:
- Publication type:
- Article
Axillary node clearance for breast cancer.
- Published in:
- Journal of the Royal College of Surgeons of Edinburgh, 1999, v. 44, n. 2, p. 111
- By:
- Publication type:
- Article
FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype.
- Published in:
- BMC Research Notes, 2011, v. 4, n. 1, p. 72, doi. 10.1186/1756-0500-4-72
- By:
- Publication type:
- Article
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
- Published in:
- American Journal of Epidemiology, 2017, v. 185, n. 2, p. 75, doi. 10.1093/aje/kww178
- By:
- Publication type:
- Article
Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.
- Published in:
- Histopathology, 2015, v. 67, n. 3, p. 279, doi. 10.1111/his.12649
- By:
- Publication type:
- Article
HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma.
- Published in:
- Histopathology, 2010, v. 56, n. 6, p. 702, doi. 10.1111/j.1365-2559.2010.03533.x
- By:
- Publication type:
- Article
Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model.
- Published in:
- International Journal of Cancer, 2009, v. 124, n. 2, p. 465, doi. 10.1002/ijc.23938
- By:
- Publication type:
- Article
Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenes.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 11, p. 2317, doi. 10.1002/ijc.22591
- By:
- Publication type:
- Article
ΔNp63 is regulated by insulin/IGF-1 signaling in normal basal/progenitor mammary cells and in luminal-type breast cancer cells.
- Published in:
- Neoplasma, 2023, v. 70, n. 5, p. 621, doi. 10.4149/neo_2023_230719N376
- By:
- Publication type:
- Article
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ductal carcinoma in situ: to treat or not to treat, that is the question.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Intraoperative Evaluation of Breast Tissues During Breast Cancer Operations Using the MasSpec Pen.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e242684, doi. 10.1001/jamanetworkopen.2024.2684
- By:
- Publication type:
- Article
High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 2, p. 355, doi. 10.1002/ijc.25034
- By:
- Publication type:
- Article
eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.
- Published in:
- Science Signaling, 2024, v. 17, n. 826, p. 1, doi. 10.1126/scisignal.adh4475
- By:
- Publication type:
- Article
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 20, p. 1963, doi. 10.1001/jama.2022.6147
- By:
- Publication type:
- Article